Lithium ionophore VI, with the CAS number 106868-21-7, is a chemical compound known for its ability to selectively transport lithium ions across lipid membranes. This characteristic makes it particularly valuable in biochemical and pharmacological research, especially in studies related to lithium's role in treating mood disorders such as bipolar disorder. The compound is a member of a class of ionophores, which are molecules that facilitate the movement of ions through cellular membranes, thereby influencing cellular processes. Lithium ionophore VI exhibits a high degree of selectivity for lithium ions over other cations, which is crucial for its function in biological systems. Its structure typically includes a hydrophobic region that interacts with lipid membranes and a polar region that coordinates with lithium ions. This unique combination of properties allows it to modulate ion concentrations within cells, making it a useful tool in both experimental and therapeutic contexts. However, detailed studies on its pharmacokinetics and potential side effects are essential for understanding its full implications in medical applications.

lithium ionophore vi

106868-21-7: Lithium ionophore VI, with the CAS number 106868-21-7, is a chemical compound known for its ability to selectively transport lithium ions across lipid membranes. This characteristic makes it particularly valuable in biochemical and pharmacological research, especially in studies related to lithium's role in treating mood disorders such as bipolar disorder. The compound is a member of a class of ionophores, which are molecules that facilitate the movement of ions through cellular membranes, thereby influencing cellular processes. Lithium ionophore VI exhibits a high degree of selectivity for lithium ions over other cations, which is crucial for its function in biological systems. Its structure typically includes a hydrophobic region that interacts with lipid membranes and a polar region that coordinates with lithium ions. This unique combination of properties allows it to modulate ion concentrations within cells, making it a useful tool in both experimental and therapeutic contexts. However, detailed studies on its pharmacokinetics and potential side effects are essential for understanding its full implications in medical applications.

6,6-Dibenzyl-14-crown-4

<p>Lithium ionophore VI is a polyvinyl chloride that contains valinomycin, a metal ion, and an organic solvent. It is used in pharmaceutical formulations as an ionophore. Lithium ionophore VI has been shown to have membrane potential-dependent transfer reactions in human serum and with the use of hydrophobic organic solvents such as chloroform and acetone. This compound can be used for calibration of analytical chemistry instruments by using it as a standard for the pH value of solutions.</p>

CAS 106868-21-7

lithium ionophore vi

6,6-Dibenzyl-14-crown-4

Ref: IN-DA008SH5

Lithium ionophore VI

Ref: 3D-FL159293